148 related articles for article (PubMed ID: 29156791)
1. The relationship between stromal cell derived SPARC in human gastric cancer tissue and its clinicopathologic significance.
Gao Y; Yin SP; Xie XS; Xu DD; Du WD
Oncotarget; 2017 Oct; 8(49):86240-86252. PubMed ID: 29156791
[TBL] [Abstract][Full Text] [Related]
2. Role of secreted protein acidic in hematogenous metastasis of gastric cancer.
Mo A; Yang SW; Jiang YX; Zhao YL; Shi Y; Qian F; Hao YX; Yu PW
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4311-4321. PubMed ID: 29077165
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of SPARC gene in human gastric carcinoma and its clinic-pathologic significance.
Wang CS; Lin KH; Chen SL; Chan YF; Hsueh S
Br J Cancer; 2004 Nov; 91(11):1924-30. PubMed ID: 15558074
[TBL] [Abstract][Full Text] [Related]
4. Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma.
Infante JR; Matsubayashi H; Sato N; Tonascia J; Klein AP; Riall TA; Yeo C; Iacobuzio-Donahue C; Goggins M
J Clin Oncol; 2007 Jan; 25(3):319-25. PubMed ID: 17235047
[TBL] [Abstract][Full Text] [Related]
5. The role of SPARC protein expression in the progress of gastric cancer.
Wang L; Yang M; Shan L; Qi L; Chai C; Zhou Q; Yao K; Wu H; Sun W
Pathol Oncol Res; 2012 Jul; 18(3):697-702. PubMed ID: 22246794
[TBL] [Abstract][Full Text] [Related]
6. Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer.
Liang JF; Wang HK; Xiao H; Li N; Cheng CX; Zhao YZ; Ma YB; Gao JZ; Bai RB; Zheng HX
J Exp Clin Cancer Res; 2010 Jun; 29(1):71. PubMed ID: 20565704
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of SPARC expression in gastric cancer: a meta-analysis.
Wang Z; Hao B; Yang Y; Wang R; Li Y; Wu Q
Arch Med Sci; 2014 Oct; 10(5):863-9. PubMed ID: 25395936
[TBL] [Abstract][Full Text] [Related]
8. High secreted protein acidic and rich in cysteine expression in peritumoral fibroblasts predicts better prognosis in patients with resectable gastric cancer.
Nakajima M; Yoshino S; Kanekiyo S; Maeda N; Sakamoto K; Tsunedomi R; Suzuki N; Takeda S; Yamamoto S; Hazama S; Hoshii Y; Oga A; Itoh H; Ueno T; Nagano H
Oncol Lett; 2018 Jan; 15(1):803-812. PubMed ID: 29403557
[TBL] [Abstract][Full Text] [Related]
9. Change of SPARC expression after chemotherapy in gastric cancer.
Gao YY; Han RB; Wang X; Ge SH; Li HL; Deng T; Liu R; Bai M; Zhou LK; Zhang XY; Ba Y; Huang DZ
Cancer Biol Med; 2015 Mar; 12(1):33-40. PubMed ID: 25859409
[TBL] [Abstract][Full Text] [Related]
10. Impact of Fibroblast-Derived SPARC on Invasiveness of Colorectal Cancer Cells.
Drev D; Harpain F; Beer A; Stift A; Gruber ES; Klimpfinger M; Thalhammer S; Reti A; Kenner L; Bergmann M; Marian B
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31554208
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and prognostic significance of SPARC expression in gastric cancer: A meta‑analysis and bioinformatics analysis.
Sun J; Bai YK; Fan ZG
Oncol Lett; 2023 Jun; 25(6):240. PubMed ID: 37181948
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of stabilin-1 positive macrophages in the early stage of gastric cancer is associated with short cumulative survival.
Yin SP; Gao Y; Xie XS; Xu DD; Riabov V; Du WD
Oncol Lett; 2020 Mar; 19(3):2404-2412. PubMed ID: 32194740
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients.
Koukourakis MI; Giatromanolaki A; Brekken RA; Sivridis E; Gatter KC; Harris AL; Sage EH
Cancer Res; 2003 Sep; 63(17):5376-80. PubMed ID: 14500371
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of SPARC expression decreases gastric cancer cellular invasion and survival.
Yin J; Chen G; Liu Y; Liu S; Wang P; Wan Y; Wang X; Zhu J; Gao H
J Exp Clin Cancer Res; 2010 Jun; 29(1):59. PubMed ID: 20525171
[TBL] [Abstract][Full Text] [Related]
15. SPARC is associated with gastric cancer progression and poor survival of patients.
Zhao ZS; Wang YY; Chu YQ; Ye ZY; Tao HQ
Clin Cancer Res; 2010 Jan; 16(1):260-8. PubMed ID: 20028745
[TBL] [Abstract][Full Text] [Related]
16. A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma.
Kao SC; Kirschner MB; Cooper WA; Tran T; Burgers S; Wright C; Korse T; van den Broek D; Edelman J; Vallely M; McCaughan B; Pavlakis N; Clarke S; Molloy MP; van Zandwijk N; Reid G
Br J Cancer; 2016 Mar; 114(5):524-31. PubMed ID: 26889976
[TBL] [Abstract][Full Text] [Related]
17. Differential Expression of SPARC in Intestinal-type Gastric Cancer Correlates with Tumor Progression and Nodal Spread.
Franke K; Carl-McGrath S; Röhl FW; Lendeckel U; Ebert MP; Tänzer M; Pross M; Röcken C
Transl Oncol; 2009 Dec; 2(4):310-20. PubMed ID: 19956393
[TBL] [Abstract][Full Text] [Related]
18. Expression of Secreted Protein Acidic and Rich in Cysteine in the Stroma of a Colorectal Carcinoma is Associated With Patient Prognosis.
Kim JY; Jeong D; Ahn TS; Kim HJ; Park DS; Park SY; Bae SB; Lee S; Lee SS; Lee MS; Cho HD; Baek MJ
Ann Coloproctol; 2013 Jun; 29(3):93-9. PubMed ID: 23862126
[TBL] [Abstract][Full Text] [Related]
19. Secreted protein acidic and rich in cysteine (SPARC) is associated with nasopharyngeal carcinoma metastasis and poor prognosis.
Wang HY; Li YY; Shao Q; Hou JH; Wang F; Cai MB; Zeng YX; Shao JY
J Transl Med; 2012 Feb; 10():27. PubMed ID: 22321704
[TBL] [Abstract][Full Text] [Related]
20. Low expression of SPARC in gastric cancer-associated fibroblasts leads to stemness transformation and 5-fluorouracil resistance in gastric cancer.
Ma Y; Zhu J; Chen S; Ma J; Zhang X; Huang S; Hu J; Yue T; Zhang J; Wang P; Wang X; Rong L; Guo H; Chen G; Liu Y
Cancer Cell Int; 2019; 19():137. PubMed ID: 31139014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
